Now showing items 1-1 of 1
Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
(American Academy of Neyurology, 2009)
Background: The frequency of HIV dementia in a recent study of HIV individuals at the Infectious Disease Institute in Kampala, Uganda, was 31%. Coformulated generic drugs, which include stavudine, are the most common ...